B001 in Patients With CD20 Positive B-cell Non Hodgkin's Lymphoma

NCT03332121 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

CD20 Positive B Cell Non-Hodgkin's Lymphoma

Interventions

BIOLOGICAL: B001

Sponsor

Shanghai Pharmaceuticals Holding Co., Ltd